Evaluating the abilities of diverse nitroaromatic prodrug metabolites to exit a model Gram negative vector for bacterial-directed enzyme-prodrug therapy.
Chan-Hyams, Jasmine V E
Evaluating the abilities of diverse nitroaromatic prodrug metabolites to exit a model Gram negative vector for bacterial-directed enzyme-prodrug therapy. [electronic resource] - Biochemical pharmacology 12 2018 - 192-200 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-2968
10.1016/j.bcp.2018.10.020 doi
Aziridines--metabolism
Dose-Response Relationship, Drug
Drug Evaluation, Preclinical--methods
Escherichia coli--drug effects
Genetic Therapy--methods
Genetic Vectors--metabolism
Humans
Nitroreductases--metabolism
Prodrugs--metabolism
Evaluating the abilities of diverse nitroaromatic prodrug metabolites to exit a model Gram negative vector for bacterial-directed enzyme-prodrug therapy. [electronic resource] - Biochemical pharmacology 12 2018 - 192-200 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-2968
10.1016/j.bcp.2018.10.020 doi
Aziridines--metabolism
Dose-Response Relationship, Drug
Drug Evaluation, Preclinical--methods
Escherichia coli--drug effects
Genetic Therapy--methods
Genetic Vectors--metabolism
Humans
Nitroreductases--metabolism
Prodrugs--metabolism